Blar i Publikasjoner fra CRIStin - NTNU på tidsskrift "mAbs"
Viser treff 1-1 av 1
-
NHDL, a recombinant VL/VH hybrid antibody control for IgG2/4 antibodies.
(Journal article; Peer reviewed, 2020)The mechanism of action of recombinant IgG2/4 antibodies involves blocking of their target without the induction of effector functions. Examples are eculizumab (Soliris®), which is used clinically to block complement factor ...